La maladie de Parkinson en France (serveur d'exploration) - Curation (PubMed)

Index « MedMesh.i » - entrée « Dihydroxyphenylalanine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Digoxin < Dihydroxyphenylalanine < Dilatation, Pathologic  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000467 (2014) Cristina Alcacer [France] ; Fanny Charbonnier-Beaupel [France] ; Jean-Christophe Corvol [France] ; Jean-Antoine Girault [France] ; Denis Hervé [France]Mitogen- and stress-activated protein kinase 1 is required for specific signaling responses in dopamine-denervated mouse striatum, but is not necessary for L-DOPA-induced dyskinesia.
000641 (2013) Matthieu F. Bastide [France]Motor cortex acquires a pivotal role in levodopa-induced dyskinesia pathophysiology.
000A03 (2010) P. Remy [France][Functional imaging: role for the diagnosis and therapeutic evaluation of Parkinson's disease].
000E77 (2005) Mathias Pessiglione [France] ; Virginie Czernecki ; Bernard Pillon ; Bruno Dubois ; Michael Schüpbach ; Yves Agid ; Léon TremblayAn effect of dopamine depletion on decision-making: the temporal coupling of deliberation and execution.
000F69 (2004) Alan L. Whone [Royaume-Uni] ; Dale L. Bailey ; Philippe Remy ; Nicola Pavese ; David J. BrooksA technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study.
001061 (2003) Stéphane Thobois [France] ; Maria-Joao Ribeiro ; Ebba Lohmann ; Alexandra Dürr ; Pierre Pollak ; Olivier Rascol ; Stéphane Guillouet ; Elizabeth Chapoy ; Nicolas Costes ; Yves Agid ; Philippe Remy ; Alexis Brice ; Emmanuel BroussolleYoung-onset Parkinson disease with and without parkin gene mutations: a fluorodopa F 18 positron emission tomography study.
001147 (2002) Andreas Hartmann [France] ; Annick Mouatt-Prigent ; Miquel Vila ; Nacer Abbas ; Céline Perier ; Baptiste A. Faucheux ; Sheela Vyas ; Etienne C. HirschIncreased expression and redistribution of the antiapoptotic molecule Bcl-xL in Parkinson's disease.
001188 (2001) S. Thobois [France] ; S. Guillouet ; E. BroussolleContributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
001198 (2001) T. Poyot [France] ; F. Condé ; M C Grégoire ; V. Frouin ; C. Coulon ; C. Fuseau ; F. Hinnen ; F. Dollé ; P. Hantraye ; M. BottlaenderAnatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
001213 (2001) A. Hartmann [France] ; J D Troadec ; S. Hunot ; K. Kikly ; B A Faucheux ; A. Mouatt-Prigent ; M. Ruberg ; Y. Agid ; E C HirschCaspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis.
001325 (1999) C. Dentresangle [France] ; L. Veyre ; D. Le Bars ; C. Pierre ; F. Lavenne ; P. Pollak ; J. Guerin ; J C Froment ; E. BrousolleStriatal D2 dopamine receptor status in Parkinson's disease: an [18F]dopa and [11C]raclopride PET study.
001551 (1996) G L Defer [France] ; C. Geny ; F. Ricolfi ; G. Fenelon ; J C Monfort ; P. Remy ; G. Villafane ; R. Jeny ; Y. Samson ; Y. Keravel ; A. Gaston ; J D Degos ; M. Peschanski ; P. Cesaro ; J P NguyenLong-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach.
001574 (1995) P. Remy [France] ; Y. Samson ; P. Hantraye ; A. Fontaine ; G. Defer ; J F Mangin ; G. Fénelon ; C. Gény ; F. Ricolfi ; V. FrouinClinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients.
001768 (1991) P. Horellou [France] ; C. Lundberg ; B. Le Bourdellès ; K. Wictorin ; P. Brundin ; P. Kalén ; A. Björklund ; J. MalletBehavioural effects of genetically engineered cells releasing dopa and dopamine after intracerebral grafting in a rat model of Parkinson's disease.
001845 (1972) M. Bonduelle ; P. Bouygues ; G. Lormeau ; C. De Maricourt[Results of L-dopa treatment in 117 patients with Parkinson's disease followed for 1 year or more].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Dihydroxyphenylalanine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Dihydroxyphenylalanine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Dihydroxyphenylalanine
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024